A recent decree issued in Peru has stirred controversy by categorizing gender and sexual diversity as pathologies.
Previously, these identities were included under the “Mental and Behavioral Disorders” chapter of the International Statistical Classification of Diseases (ICD-10).
However, the updated version of the ICD-10, effective from 2022, no longer considers them as such.
Rejection by Feminist Groups
Following the publication of the decree, feminist organizations like Manuela Ramos expressed strong opposition, raising concerns about the potential promotion of “conversion therapies.”
They argue that the regulation seeks to pathologize gender and sexual diversity, demanding its immediate repeal to prevent further stigmatization and discrimination.
Response from the Ministry of Health
Amid mounting criticism, the Peruvian Ministry of Health (Minsa) released a statement reaffirming its stance that gender and sexual diversity are not diseases.
The ministry emphasized respect for gender identities and rejected the stigmatization of sexual diversity.
Additionally, Minsa clarified that sexual orientation and gender identity do not constitute mental health disorders and should not be subjected to medical treatments or conversion therapies.
Continued Enforcement of the Decree
Despite the Ministry of Health’s statement, the controversial decree labeling gender and sexual diversity as pathologies remains in effect.
As of now, there have been no modifications or repeals to the decree, leaving many concerned about its potential implications for the rights and well-being of individuals, families, and communities in Peru.
World News